Newsfiscal.ai
Enanta Pharmaceuticals Announces Planned Retirement of CEO Jay R. Luly
· Published
Article summary
Enanta Pharmaceuticals, Inc. announced that its President and Chief Executive Officer, Jay R. Luly, Ph.D., will retire by February 1, 2027, after 23 years of leadership.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…